Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-small Cell Lung Cancer

Introduction With the incorporation of modernized radiotherapy, chemotherapy, and immunotherapy, treatment outcomes have improved for patients with locally advanced, unresectable diseases. Elderly or poor performance status patients comprise more than half of non-small cell lung cancer (NSCLC) patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu M, Shin, Jacob, Jelinek, Michael, Fidler, Mary J, Batus, Marta, Bonomi, Philip D., Marwaha, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586742/
https://www.ncbi.nlm.nih.gov/pubmed/36299962
http://dx.doi.org/10.7759/cureus.29423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586742/
https://www.ncbi.nlm.nih.gov/pubmed/36299962
http://dx.doi.org/10.7759/cureus.29423

Ejemplares similares